Abstract
Pulmonary complications associated with autoimmune connective tissue disease (CTD) are common causes of clinical interstitial lung disease (ILD). Pleural manifestations are dominated by inflammation and varying amounts of diffuse fibrosis. In the lung, a wide spectrum of histologic injury patterns are encountered in every anatomic location including small airway disease most commonly in the form of chronic bronchiolitis, vascular changes, and interstitial lung disease ranging from diffuse alveolar damage to advanced pulmonary fibrosis. The most common interstitial pattern, seen in nearly all of the different CTDs, is a cellular and variably fibrotic ILD referred to as nonspecific interstitial pneumonia (NSIP). Each of the major CTDs has particular manifestations more commonly manifested, but the histopathologic changes found in these CTDs are often not specific and a definitive diagnosis usually requires detailed clinical, serologic, and pathologic correlation as well as close patient follow-up.
Keywords: Interstitial lung disease, mixed connective tissue disease, rheumatic lung disease, rheumatoid lung, scleroderma, Sjogren syndrome, systemic lupus erythematosus.
Current Respiratory Medicine Reviews
Title:Histopathology of Connective Tissue Disease-Associated Pleuropulmonary Disease
Volume: 11 Issue: 2
Author(s): Maxwell Smith, Brandon Larsen, Henry Tazelaar and Kevin Leslie
Affiliation:
Keywords: Interstitial lung disease, mixed connective tissue disease, rheumatic lung disease, rheumatoid lung, scleroderma, Sjogren syndrome, systemic lupus erythematosus.
Abstract: Pulmonary complications associated with autoimmune connective tissue disease (CTD) are common causes of clinical interstitial lung disease (ILD). Pleural manifestations are dominated by inflammation and varying amounts of diffuse fibrosis. In the lung, a wide spectrum of histologic injury patterns are encountered in every anatomic location including small airway disease most commonly in the form of chronic bronchiolitis, vascular changes, and interstitial lung disease ranging from diffuse alveolar damage to advanced pulmonary fibrosis. The most common interstitial pattern, seen in nearly all of the different CTDs, is a cellular and variably fibrotic ILD referred to as nonspecific interstitial pneumonia (NSIP). Each of the major CTDs has particular manifestations more commonly manifested, but the histopathologic changes found in these CTDs are often not specific and a definitive diagnosis usually requires detailed clinical, serologic, and pathologic correlation as well as close patient follow-up.
Export Options
About this article
Cite this article as:
Smith Maxwell, Larsen Brandon, Tazelaar Henry and Leslie Kevin, Histopathology of Connective Tissue Disease-Associated Pleuropulmonary Disease, Current Respiratory Medicine Reviews 2015; 11 (2) . https://dx.doi.org/10.2174/1573398X11666150619175744
DOI https://dx.doi.org/10.2174/1573398X11666150619175744 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pulmonary Arterial Hypertension
Current Vascular Pharmacology Current Status of Pharmacological Thrombolytic Therapy and Mechanical Thrombectomy for the Treatment of Acute Deep Venous Thrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Current and Experimental Antibody-Based Therapeutics: Insights, Breakthroughs, Setbacks and Future Directions
Current Molecular Medicine Current Treatment of the Pulmonary Arterial Hypertension
Current Respiratory Medicine Reviews Neurocognitive Monitoring and Care During Pediatric Cardiopulmonary Bypass — Current and Future Directions
Current Cardiology Reviews Vascular Toxicity of Chemotherapeutic Agents
Current Vascular Pharmacology Pathophysiological Basis for Anticoagulant and Antithrombotic Therapy in Pulmonary Hypertension
Cardiovascular & Hematological Agents in Medicinal Chemistry Advances in Drug Safety
Current Pharmaceutical Design Impact of Pulmonary Vascular Resistances in Heart Transplantation for Congenital Heart Disease
Current Cardiology Reviews Thrombotic Microangiopathy and Occult Neoplasia
Cardiovascular & Hematological Disorders-Drug Targets Potential Role of ADAMTS13 in the Progression of Alcoholic Hepatitis
Current Drug Abuse Reviews Treatment of Pulmonary Edema by ENaC Activators/Stimulators
Current Molecular Pharmacology Drug-Induced Thromboembolic Events in Patients with Malignancy
Cardiovascular & Hematological Disorders-Drug Targets Clinical Applications of Cardiac Multi-Slice Computed Tomography
Current Medical Imaging Busulfan Use in Hematopoietic Stem Cell Transplantation: Pharmacology, Dose Adjustment, Safety and Efficacy in Adults and Children
Current Drug Safety Intravenous Immunoglobulin Preparations and Autoimmune Disorders: Mechanisms of Action
Current Pharmaceutical Biotechnology Approaches to the Management of Acute Kidney Injury in Children
Recent Patents on Biomarkers Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis
Current Drug Targets Pulmonary Hypertension in the Critically Ill
Current Hypertension Reviews Peripartum Cardiomyopathy: An Intensivist's Perspective
Current Women`s Health Reviews